Who owns Synta Pharmaceuticals?
Key information on Synta Pharmaceuticals (Ticker: SNTA)
- CUSIP: 87162T206
Who owns Synta Pharmaceuticals?
Is SNTA a good stock to own? Find out who bought Synta Pharmaceuticals, who sold Synta Pharmaceuticals (SNTA) stock, and who holds a large position in Synta Pharmaceuticals.
- Jennison Associates owns 2.42M shares worth $20.80M
- Sectoral Asset Management owns 1.48M shares worth $11.30M
- JPMORGAN CHASE & CO owns 1.42M shares worth $7.77M
- QVT Financial owns 1.34M shares worth $11.52M
- Baker Bros. Advisors owns 1.31M shares worth $10.00M
- Perceptive Advisors owns 1.09M shares worth $9.40M
- Vanguard owns 941803 shares worth $8.10M
- Ayer Capital Management owns 851635 shares worth $3.70M
- Manatuck Hill Partners owns 784116 shares worth $6.74M
- Driehaus Capital Management owns 713498 shares worth $6.14M
- STATE STREET CORPORATION owns 616036 shares worth $5.30M
- GOLDMAN SACHS owns 601222 shares worth $5.18M
- Scoggin owns 559000 shares worth $4.81M
- Barclays owns 421900 shares worth $3.63M
- Jefferies owns 421200 shares worth $2.30M
- Ridgeback Capital Investments owns 411306 shares worth $2.25M
- Taylor Investment Counselors owns 410870 shares worth $3.53M
- T. Rowe Price Associates owns 323000 shares worth $2.78M
- Technical Financial Services owns 266465 shares worth $1.46M
- TIAA-CREF Investment Management owns 252095 shares worth $2.17M
- S.A.C. Capital Advisors owns 250000 shares worth $2.15M
- PointState Capital owns 200000 shares worth $1.80M
- First Eagle Investment Management owns 200000 shares worth $870000
- Geode Capital Management owns 166924 shares worth $1.44M
- D. E. Shaw & Co owns 147719 shares worth $1.13M
- Bridgeway Capital Management owns 142500 shares worth $625575
- Balyasny Asset Management owns 130966 shares worth $1.13M
- J. Goldman & Co owns 130000 shares worth $1.12M
- Hambrecht & Quist Capital Management owns 129000 shares worth $1.11M
- Charles Schwab Bank owns 126420 shares worth $14.70M
- Renaissance Technologies owns 126400 shares worth $1.09M
- Sigma Capital Management owns 121508 shares worth $925890
- Private Capital Advisors owns 117000 shares worth $891540
- Credit Suisse AG owns 110446 shares worth $949835
- Millennium Management owns 108040 shares worth $929144
- Teachers Advisors owns 101395 shares worth $871997
- Smithwood Advisers owns 100000 shares worth $860000
- Charles Schwab Investment Management owns 96918 shares worth $850940
- CalPERS owns 94678 shares worth $411849
- ALLIANCEBERNSTEIN owns 92007 shares worth $791260
- Thomas Stevens, CFA" owns 84296 shares worth $393662
- Oxford Asset Management owns 74123 shares worth $669330
- California State Teachers Retirement System owns 68972 shares worth $593159
- Frank Russell Company owns 67792 shares worth $607416
- UBS AG owns 66600 shares worth $572760
Who sold Synta Pharmaceuticals?
- RA Capital Management sold on Sept. 30, 2011
- Redmile sold on Sept. 30, 2011
- Neuberger Berman sold on June 30, 2011
- Michael F. Price sold on March 31, 2011
- Citi sold on March 31, 2011
- FMR sold on Dec. 31, 2010
- ClariVest Asset Management sold on Dec. 31, 2010
- Maverick Capital sold on March 31, 2007
Funds that own SNTA also own:
- BioMarin Pharmaceutical (BMRN)
- Teva Pharmaceutical Industries (TEVA)
- Vertex Pharmaceuticals Incorporated (VRTX)
- Mylan (MYL)
- Allergan (AGN)
- Biogen Idec (BIIB)
- Gilead Sciences (GILD)
- Shire (SHPGY)
- Novo Nordisk A/S (NVO)
- Illumina (ILMN)
- Array BioPharma (ARRY)
- Onyx Pharmaceuticals (ONXX)
- ArQule (ARQL)
- Perrigo Company (PRGO)
- Synta Pharmaceuticals (SNTA)
- Alexion Pharmaceuticals (ALXN)
- Celgene Corporation (CELG)
- Medivation (MDVN)
- Pharmacyclics (PCYC)
- Ariad Pharmaceuticals (ARIA)
- Amarin Corporation (AMRN)